Veterinary product manufacturer Heska Corporation agreed to buy US-based veterinary telemedicine platform Lacuna Diagnostics for an undisclosed amount yesterday in a deal allowing advertising agency R/GA to exit.
Founded in 2016, Lacuna provides a telemedicine cytology platform that enables veterinarians to send images of pet patient samples to board-certified pathologists for rapid diagnosis.
The company has interpreted more than 25,000 patient cases and saved more than 86,000 hours for the clients that use its platform.
Heska chief executive officer and president Kevin Wilson said it is acquiring Lacuna to double its product and revenue streams. The transaction is expected to close by the end of March 2021.
In 2018, Lacuna was selected to participate in Leap Venture Studio, a petcare-focused accelerator held in partnership with pet product supplier Mars Petcare, non-profit organisation Michelson Found Animals Foundation and R/GA’s investment arm, R/GA Ventures, which has named it as a portfolio company.
Lacuna received a $100,000 grant from the Colorado Office of Economic Development & International Trade in 2017 and joined Rockies Venture Club Hyper Accelerator Program.